[1] Woischneck D, Eder A, Holstege A, et al. Severe dyspnea by combination of cervical spondylosis and struma. Dtsch Med Wochenschr. 2015;140(11): 824-826.
[2] Bunyaratavej K, Montriwiwatnchai P, Siwanuwatn R, et al. Localizing value of pain distribution patterns in cervical spondylosis. Asian Spine J. 2015;9(2): 210-217.
[3] Singh S, Kumar D, Kumar S. Risk factors in cervical spondylosis. J Clin Orthop Trauma. 2014;5(4): 221-226.
[4] Zhou YJ, Li WY. Issues in the diagnosis and treatment of cervical spondylosis. Zhongguo Gu Shang. 2013; 26(10):849-852.
[5] Wu J, Liu Y, Chen W. Surgical management of dysphagia and dyspnea secondary to esophagus type cervical spondylosis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;50(2):160-161.
[6] Duan C, Wu J, Hu J, et al. Treatment of multi-segmental cervical spondylosis by long or segmented anterior cervical decompression and fixation surgery.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(12):1306-1312.
[7] Zhao DL. The design of a model of the experimental cervical spondylosis. Zhonghua Wai Ke Za Zhi. 1993; 31(8):453-455.
[8] Miyamoto S, Yonenobu K, Ono K. Experimental cervical spondylosis in the mouse. Spine (Phila Pa 1976). 1991;16(10 Suppl):S495-500.
[9] Wang YJ, Shi Q, Zhou Q, et al. A rabbit model of cervical spondylosis established by stimulation of wind, cold and dampness. Zhong Xi Yi Jie He Xue Bao. 2007; 5(1):39-44.
[10] SaterenZoller E, Cannella D, Chyatte D, et al. Diagnosis and medical and surgical management of cervical spondylotic myelopathy. JAAPA. 2015;28(10): 29-36.
[11] Hoffman H, Lee SI, Garst JH, et al. Use of multivariate linear regression and support vector regression to predict functional outcome after surgery for cervical spondylotic myelopathy. J Clin Neurosci. 2015;22(9): 1444-1449.
[12] Klironomos G, Karadimas S, Mavrakis A, et al. New experimental rabbit animal model for cervical spondylotic myelopathy. Spinal Cord. 2011;49(11): 1097-1102.
[13] Tetreault LA, Côté P, Kopjar B, et al. A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients. Spine J. 2015;15(3):388-397.
[14] Karadimas SK, Moon ES, Yu WR, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. Neurobiol Dis. 2013;54:43-58.
[15] Lee J, Satkunendrarajah K, Fehlings MG. Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes. J Neurotrauma. 2012; 29(5):1012-1027.
[16] Yu WR, Liu T, Kiehl TR, et al. Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy. Brain. 2011;134(Pt 5):1277-1292.
[17] 徐远坤,张燕,陈久毅.大鼠脊髓型颈椎病动物模型初探[J].中国中医骨伤科杂志,2007,15(3):19-21.
[18] 赵玲.骨水泥压近钉建立脊髓型颈椎病动物模型的研究[D].石家庄:河北医科大学,2011.
[19] 胡志俊,卞琴,王拥军,等.大鼠脊髓慢性压迫性损伤动物模型的建立[J].脊柱外科杂志,2004,2(4):216-219.
[20] 王军,韦峰,汪辉亮,等.慢性颈脊髓压迫模型大鼠构建及评价[J].中国组织工程研究,2013,18(7):1196-1200.
[21] 张红利,沈霖.颈椎病兔模型TNF-а、SP、NPY、CGRP的变化及意义[J].数理医药学杂志,2012,25(4):410-412.
[22] 张欣,李殿宁,李开平,等.无创兔颈型颈椎病动物模型的建立[J].中华中医药学刊,2015,33(4):913-916.
[23] Omidi-Kashani F, Hasankhani EG, Vavsari MF, et al. Functional Outcomes of Surgery in Cervical Spondylotic Radiculopathy versus Myelopathy: A Comparative Study. Neurosci J. 2013;2013:293806.
[24] Kadoya S, Iizuka H, Nakamura T. Long-term outcome for surgically treated cervical spondylotic radiculopathy and myelopathy. Neurol Med Chir (Tokyo). 2003;43(5): 228-240.
[25] Gao SM, Guo H, Zhao XF, et al. Clinical study on curing the cervical spondylotic radiculopathy with the methods of Blade needle closed loosing and reduction with traction at the same time. Zhongguo Gu Shang. 2012;25(1):14-17.
[26] Kumaresan S, Yoganandan N, Pintar FA, et al. Contribution of disc degeneration to osteophyte formation in the cervical spine: a biomechanical investigation. J Orthop Res. 200;19(5):977-984.
[27] 赵伟宏.川芎提取物对神经根型颈椎病根性疼痛治疗作用及机制研究[D].广州:南方医科大学,2015.
[28] 孔微微.小鼠CCD模型和颈椎神经根性病变模型建立及机制研究[D]. 温州:温州医学院,2011.
[29] 梅荣军,高新,武亮,等.推拿治疗神经根型颈椎病的动物模型研究[J].中医药信息,2007,24(5):58-59.
[30] 杜思邈,张忠亮,李强,等.神经根型颈椎病大鼠气虚血瘀证候变化规律研究[J].中国中医药科技,2013,20(5): 441-442.
[31] 杨大志.神经根慢性嵌压损伤的动物模型建立[J].中国脊柱脊髓杂志,2004,14(5):290-294.
[32] 张军,孙树椿.神经根型颈椎病(急性期)动物模型的建立[J].中国中医骨伤科杂志,2000,8(1):12-16.
[33] 金哲峰,徐凡平,朱立国,等.慢性神经根型颈椎病动物模型的建立[J].天津中医药,2015,32(9):558-562.
[34] Xu M, Li X, Wang J, et al. Application of a new combined model including radiological indicators to predict difficult airway in patients undergoing surgery for cervical spondylosis. Chin Med J (Engl). 2014; 127(23):4043-4048.
[35] Huang ZJ, Chen JX, Qi WW. Clinical research on treatment of vertebroarterial type of cervical spondylosis with 5-step manipulation and traction. J Tradit Chin Med. 2009;29(4):268-270.
[36] Zhang CW, Wu JJ, Han Y, et al. Experimental study of eliminat dampness resolv phlegm method in treating cervical spondylopathy of the vertebral artery type. Zhongguo Gu Shang. 201;23(7):534-537.
[37] Shou Z, Shen L, Xiong P. Assessing the validity of a novel model of vertebral artery type of cervical syndrome induced by injecting sclerosing agent next to transverse process of cervical vertebra. J Huazhong Univ Sci Technolog Med Sci. 2010;30(1):85-88.
[38] 李俊华.椎动脉受压动物模型血浆内皮素的变化[J].中国中医骨伤科杂志,2003,11(5):16-18
[39] 皮全民,谢明夫,梁帮领.椎动脉型颈椎病动物模型的建立[J].当代医学,2008,14(7):30-31.
[40] 张文芽,陈惠德,唐淼. 核因子κB、白介素-6在动静力失衡性大鼠退变颈椎间盘中的表达[J].中国运动医学杂志, 2011,30(2):158-161.
[41] 郭建阔,李卫华,李继锋,等.椎动脉型颈椎病动物模型的病理学研究[J].中外医疗,2014,33(4):35-36. |